Rating Change
Citigroup reiterated its Neutral rating on Health Catalyst, Inc. (NASDAQ:HCAT) on August 11, 2026.
reiterateNASDAQ:HCAT
Citigroup Reiterates Neutral Rating on Health Catalyst, Inc. (HCAT)
Citigroup reiterated its Neutral rating on Health Catalyst, Inc. (NASDAQ:HCAT) on August 11, 2026.
At publication ·
What changed
Health Catalyst, Inc. (NASDAQ:HCAT) · reiterate
- Firm
- Citigroup
- Rating
- Neutral to Neutral
- Price at event
- $1.76
- Market capitalization
- $181.1M
At a glance
Key takeaways
- Citigroup reiterated a Neutral rating on Health Catalyst, Inc. (HCAT) on August 11, 2026, with the stock trading at $1.76 and a market capitalization of $181.1 million.
Market Context
Health Catalyst, Inc. operates in the Healthcare sector. The stock currently trades at $1.76 with a market capitalization of $181.1M.
Analyst coverage from Citigroup provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Health Catalyst, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Health Catalyst, Inc.
Among the 10 most recent ratings: 2 Buy, 8 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | Citigroup | Neutral | N/A |
| Jul 21, 2026 | Canaccord Genuity | Buy | N/A |
| Jun 26, 2026 | Wells Fargo | Equal-Weight | N/A |
| May 12, 2026 | Stephens & Co. | Equal-Weight | N/A |
| Mar 18, 2026 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View HCAT Stock Page
Frequently Asked Questions
What does the Neutral rating mean for HCAT?
A rating of Neutral from Citigroup reflects the analyst's outlook on Health Catalyst, Inc. (NASDAQ:HCAT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HCAT forecast page.